The retooled Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4 and BA.5, the companies said.
The data, which the companies reported in a news release Thursday, offer the first window into how the new shots rolling out across the U.S. perform.
